Sarah Van Orman, USC’s Chief Health Officer for USC Student Health, shares updates regarding COVID-19 vaccine distribution.
Keck Medical Center of USC and USC Verdugo Hills Hospital have received their first shipments of the Pfizer-BioNTech COVID-19 vaccine.
Sarah Van Orman, USC’s Chief Health Officer for USC Student Health, announces the university’s expanded COVID-19 testing capacity for Spring 2021.
Rod Hanners, Interim Chief Executive Officer of Keck Medicine of USC, will chair a COVID-19 vaccine working group that is principally engaged in developing an evidence-based strategy for the vaccination of USC staff, faculty, students, and patients.
Employees and supervisors should review the details about USC’s screening, symptom and exposure reporting process for employees who are working onsite.
We are deeply troubled by the updated guidance that U.S. Immigration and Customs Enforcement (ICE) released Monday requiring international students to take at least one in-person class to maintain their visa status. Given the broad range of courses being offered, both in person and online, we are optimistic we will be able to support our international students to study in person safely if they wish, but it may take a few days.
Our decisions for the fall semester require that we remain nimble, especially as COVID-19 cases in Southern California continue to rise. Reducing on-campus density in buildings, outdoors and during activities will be needed to ensure your safety and to comply with L.A. County Department of Health guidelines.
Felicia Washington, Senior Vice President of Human Resources, and Charles Zukoski, Provost and Senior Vice President for Academic Affairs, share an important update with faculty and staff on COVID-19 training and daily wellness checks.
As we begin a phased approach toward resuming some on-campus activities, Provost Charles Zukoski shares the progress we have made in a number of areas.
USC has a potential budget gap of $300 to $500 million in FY 2021. The gap arises from lost revenues and increased costs associated with COVID-19. We are preparing for a prolonged economic recovery that could impact our finances for several years. We remain confident that we can close this gap for FY 2021, and over the next year, develop plans to emerge stronger from the pandemic.